Reintroducing the Sodium–Iodide Symporter to Anaplastic Thyroid Carcinoma-Reference-Cited by-同舟云学术

Reintroducing the Sodium–Iodide Symporter to Anaplastic Thyroid Carcinoma

Published:2017-12 Issue:12 Volume:27 Page:1534-1543
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Schmohl Kathrin A.¹,Dolp Patrick¹,Schug Christina¹,Knoop Kerstin¹,Klutz Kathrin¹,Schwenk Nathalie¹,Bartenstein Peter²,Nelson Peter J.¹,Ogris Manfred³,Wagner Ernst⁴,Spitzweg Christine¹

Affiliation:

1. Department of Internal Medicine IV, University Hospital of Munich, LMU Munich, Munich, Germany.

2. Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany.

3. Department of Pharmaceutical Chemistry, Laboratory of MacroMolecular Cancer Therapeutics (MMCT), University of Vienna, Vienna, Austria.

4. Department of Pharmaceutical Biotechnology, Department of Pharmacy, Center for System-Based Drug Research and Center for Nanoscience, LMU Munich, Munich, Germany.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2017.0290

Reference59 articles.

1. The sodium iodide symporter: its pathophysiological and therapeutic implications

2. RADIOACTIVE IODINE THERAPY

3. The Sodium Iodide Symporter and Its Potential Role in Cancer Therapy

4. The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications

5. Personalized Therapy in Patients With Anaplastic Thyroid Cancer: Targeting Genetic and Epigenetic Alterations

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surface engineered multifunctional nano-systems for localised drug delivery against thyroid cancer: A review of current practices;Biomedicine & Pharmacotherapy;2024-07

2. Nanotechnological Advancements for the Theranostic Intervention in Anaplastic Thyroid Cancer: Current Perspectives and Future Direction;Current Cancer Drug Targets;2024-03

3. Role of sodium/iodide symporter overexpression in inhibiting thyroid cancer cell invasion and stem cell maintenance by inhibiting the β-catenin/LEF-1 pathway;Heliyon;2024-03

4. Nuklearmedizin bei anaplastischem Schilddrüsenkrebs;Nuklearmedizin bei endokrinen Erkrankungen;2024

5. Customizing cancer treatment at the nanoscale: a focus on anaplastic thyroid cancer therapy;Journal of Nanobiotechnology;2023-10-13